Tuberculosis in Biological Technology

CEL-SCI Files Patent Application to Support Company's Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses

... University of Hawaii ) reported new L.E.A.P.S. tuberculosis data at the Annual American Society for ... with specificity for particular Mycobacterium tuberculosis (TB) antigens can elicit immune responses that would be expected to be protective against tuberculosis and have the potential to treat swine and other ...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... of latent tuberculosis. Patients with tuberculosis have frequently presented with disseminated or ... disease. Patients should be tested for latent tuberculosis before CIMZIA use and during therapy. Treatment ... CIMZIA, including the possible development of tuberculosis in patients who tested negative for ...

Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

... Test for Mycobacterium tuberculosis (TB) Expected to Highlight Broad On-Demand CE IVD ... Leeds 10:00 Do We Need Rapid Tests to Detect tuberculosis and Rifampicin Resistance? ... our Xpert(R) MTB/RIF test for Mycobacterium tuberculosis - a product that, in my opinion, is one of the ...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... patients with severe infections such as sepsis, tuberculosis and opportunistic infections and in patients who ... to initiation of SIMPONI. Treatment of latent tuberculosis infection should be initiated prior to therapy ... several or highly significant risk factors for tuberculosis infection and have a negative test for ...

Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)

... the speed of diagnosis of Mycobacterium tuberculosis (TB) and the resistance to common drug treatment ... billion people are infected with Mycobacterium tuberculosis . Each year approximately nine million people ... "The need for accurate and rapid detection of tuberculosis is becoming increasingly acute with the ...

Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609

... preclinical development of the company's novel tuberculosis (TB) lead dipiperidine drug compound, SQ609. ... single-drug activity against Mycobacterium tuberculosis in vitro and in vivo , SQ609 has demonstrated ... be readily synthesized on a large scale. tuberculosis (TB) is the cause of the largest number of human ...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

... visit http://www.ucb-group.com . tuberculosis (frequently disseminated or extrapulmonary at ... treatment of patients with latent tuberculosis infection reduces the risk of reactivation in ... blockers such as CIMZIA (R) . However, active tuberculosis has developed in patients receiving CIMZIA (R) ...

Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis

... and marketing of a new vaccine against tuberculosis (TB), a disease that causes the death of ... certain fusion proteins in the development of a tuberculosis vaccine. The license from SSI includes access to ... a very important step in the fight against tuberculosis and for SSI. "SSI is one of the world's leading ...

Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis

... Kalispell to Key West for Accurate & Effective tuberculosis Screening October 12 2007 - Valencia CA. - ... can now quickly and accurately detect M. tuberculosis infection with today's U.S. Food and Drug ... to proteins specifically associated with tuberculosis (TB) infection. It replaces the original ...

One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study

... week 52, 5 percent of golimumab-treated patients experienced SAEs and no tuberculosis or opportunistic infections were reported. Between weeks 24 and 52, one ... associated with serious and sometimes fatal risks including the risk of tuberculosis and other serious infections, malignancies, heart failure, central nervous ...

US College Students Needing TB Testing Now Have the Benefit of QFT(TM)

... Aug. 28 /PRNewswire/ -- Students attending US colleges that require tuberculosis (TB) testing will now benefit from interferon-gamma release assays (IGRA) ... 16 2005, Vol. 54, No. RR-15. Veeser PI, Smith PK, Handy B, Martin SR. tuberculosis screening on a health science campus: use of QuantiFERON-TB Gold test for ...

Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy

... assays such as QuantiFERON(R)-TB Gold (QFT(TM)) for screening patients for tuberculosis (TB) infection prior to initiating biological treatments (such as ... treatment should be offered to all patients with evidence of latent tuberculosis infection before starting anti-TNF-a therapy. For patients with a positive ...

Sequella Lead Drug Compound SQ109 Receives Orphan Drug Status From the US FDA and Orphan Medicinal Product Designation From the European Medicines Agency for the Treatment of Tuberculosis

... Orphan Medical Product Designation of SQ109 for the treatment of tuberculosis entitles Sequella to incentives such as protocol assistance (scientific ... also received Fast Track Status from the FDA in January of 2007. About tuberculosis (TB) TB is a contagious infectious disease caused by the ...

Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust

... damage to internal organs, is often fatal if left untreated. -- tuberculosis is a worldwide health problem. Caused by Mycobacterium tuberculosis infection, every fifteen seconds someone in the developing world dies ...

Bacteria pack their own demise

... Escherichia coli bacteria, more commonly known as E.coli, have such a T-A system in five different locations in their DNA, while Mycobacterium tuberculosis bacteria even have them in 60 locations. A difficult feat The T-A mechanism has been known for a while, but nobody clearly understood the ...

Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo

... system performs four tests on one automated platform: culture for blood, sterile body fluids, and mycobacteria detection, as well as Mycobacterium tuberculosis (TB) susceptibility testing. With a proven "tough-bug" advantage and reduced time to detection, Trek designed the VersaTREK system to improve patient ...

Ten Top Latin American Scientists Named 2009 Pew Fellows in the Biomedical Sciences

... Kelly Grace Magalhaes, Ph.D. Laboratory of David B. Moody, M.D. Brigham and Women's Hospital tuberculosis and the immune system Joao P.B. Monteiro, M.D., Ph.D. Laboratory of Ronald N. Germain, Ph.D. ...

Australia: Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight

... kills germs including those that cause Influenza A (including pandemic strains such as Swine flu), Herpes, common colds, measles, pneumonia, SARS, tuberculosis and MRSA. By targeting only the dangerous elements, BioFriend's intelligent filtration technology optimizes breathability and comfort. With its ...

Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109

... sensitive and both multi-drug resistant and extensively-drug resistant (MDR and XDR) Mycoba c terium tubercul o sis , the causative agent of tuberculosis (TB). The Phase 1B study will assess safety, pharmacokinetics and tolerability of multiple ascending doses of SQ109 in three cohorts of healthy ...

Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again

... Journal (Lancet) study, researchers summarized that UVGI ... be useful in the broader effort to combat contagious diseases such as flu, SARS, tuberculosis and cold viruses. If a large number of schools, office buildings and residences were modified (to included ... respiratory diseases ...

Cepheid Reports 2009 First Quarter Results

... released our Xpert(R) MRSA/SA-nasal product in Europe for pre-surgical testing, and expect to release our Xpert(R) TB/RIF for multi-drug resistant tuberculosis in Europe next week. Additionally, I am pleased to announce that we have submitted our Clostridium difficile assay to the FDA for 510(k) market ...

Mylan's Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments

... sustainable and predictable funding to increase access and reduce prices of quality drugs and diagnostics for the treatment of HIV/AIDS, malaria and tuberculosis in developing countries. UNITAID-CHAI projects supply ARVs for pediatric and adult second-line treatment in 42 developing countries. The group's ...

New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis

... If a serious infection develops, monitor patients carefully and stop STELARA until the infection resolves. Patients should be evaluated for tuberculosis (TB) infection prior to initiating treatment with STELARA. STELARA is a selective immunosuppressant. Immunosuppressive agents have the ...

Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program

... pneumonia of the elderly, sexually transmitted infections (such as genital herpes, syphilis, and chlamydia), and the pandemic infections of tuberculosis and malaria. "The worldwide recognition of the potential for vaccines -- increased use of existing, improved and new -- creates the ...

Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis

... died from diarrhea, colitis and sepsis. Anti-TNF therapies have been associated with serious and sometimes fatal risks including the risk of tuberculosis and other serious infections, malignancies, heart failure, central nervous system disorders, reactivation of hepatitis B and other serious events. ...

BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World

... industry resources are integral to the discovery of new solutions for the millions of patients suffering from diseases such as malaria, tuberculosis and African sleeping sickness." Barriers such as insufficient markets, funding, and information continue to deter industry from applying their ...

Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

... 7 /PRNewswire-FirstCall/ -- The Lilly TB Drug Discovery Initiative today announced its first acquisition of compounds for further development into tuberculosis (TB) drug candidates. Agreements were reached with Summit plc (LSE: SUMM) of Oxfordshire, UK, and the Microbial Chemistry Research Foundation (MCRF) ...

The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

... 7 /PRNewswire-FirstCall/ -- The Lilly TB Drug Discovery Initiative today announced its first acquisition of compounds for further development into tuberculosis (TB) drug candidates. Agreements were reached with Summit plc (LSE: SUMM) of Oxfordshire, UK, and the Microbial Chemistry Research Foundation (MCRF) ...

Pharmaxis Research Programs Highlighted at European Respiratory Society Congress

... as treatment for children with cystic fibrosis -- Implications for everyday practice -- Infectious lung diseases including tuberculosis -- A randomized, placebo-controlled trial of inhaled mannitol(Bronchitol) in patients with bronchiectasis -- Cough and airway ...

Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value

... a Chinese and an international patent for recombinant human kallikrein-1 (rhK1), and for a Chinese patent for an innovative recombinant multivalent tuberculosis vaccine. -- Continuing penetration of Chinese market of Sinobiomed's commercialized products, which treat a wide range of diseases ...

Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today

... a partnered S. aureus vaccine in Phase II, a therapeutic vaccine against Hepatitis C in Phase II, a Pseudomonas vaccine in Phase II, a partnered tuberculosis vaccine (Phase I/II), and five products focused on infectious diseases in preclinical development. Intercell is listed on the Prime Market of the ...

World Allergy Organization Highlights Global Allergy Impact

... people worldwide experience allergic rhinitis and 300 million people worldwide have asthma(1) with estimated economic costs exceeding those of tuberculosis and HIV/AIDS combined.(2) One of the most alarming findings from the report is that while the incidence of allergy and associated diseases has ...

Brazil's biotech firms: From imitators to innovators in health-related products

... rural settings in Brazil, a market usually neglected by large companies. Katal is responding to Brazil's approximately 140.000 annual cases of tuberculosis by developing a $25 TB test to replace the current $150 version. It also supplies the public health system with an innovative test for screening the ...

New discoveries, new labs highlight international Canadian Light Source meeting

... Meeting plenary session on June 9. Presentations cover the range of disciplines touched by synchrotron light, ranging from a drug target for treating tuberculosis and the possible key to improving crop production, to understanding the role soil minerals and bacteria play in the capture and storage of carbon, ...

Glowing zebrafish help researchers track role of sugars in the cell

... cells or organism. Bertozzi has focused on making it just as easy to study the sugars on cells, in part to investigate their role in such diseases as tuberculosis and influenza. In the latter, the flu virus enters cells by way of hemagglutinin, a sugar-protein complex on the viral surface that attaches to ...

Engineers harness cell phone technology for use in medical imaging

... X-rays, magnetic resonance images, and other medical imaging technology used for a wide range of applications, from detecting tumors to confirming tuberculosis infections to monitoring developing fetuses. "Medical imaging is something we take for granted in industrialized countries," said Boris Rubinsky, ...

Researchers develop method for transmitting medical images via cell phones

... resonance images and other medical imaging technology used for a wide range of applications, from detecting tumors to confirming signs of active tuberculosis infections to monitoring the health of developing fetuses during pregnancy. The conventional medical imaging systems in use today -- ...

Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: NPHC, PECD, PNRR

... is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI). Nutra Pharma continues to identify and acquire intellectual property and companies in ...

The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems' CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.

... The Forum follows a report last month from the World Health Organization (WHO) revealing that drug resistant tuberculosis has hit the highest levels ever recorded. According to a survey of over 90,000 TB patients in 81 countries, the WHO found that levels of multi-drug ...

QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes

... treating various respiratory and/or pulmonary diseases including, but not limited to, asthma, chronic obstructive pulmonary disease, emphysema, tuberculosis and pulmonary arterial hypertension. About QED International Associates QED International, based in New York, is a leading financial ...